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Summary
Background Food allergy is a common cause of anaphylaxis, but the incidence of fatal
food anaphylaxis is not known. The aim of this study was to estimate the incidence of
fatal food anaphylaxis for people with food allergy and relate this to other mortality risks
in the general population.
Methods We undertook a systematic review and meta-analysis, using the generic inverse
variance method. Two authors selected studies by consensus, independently extracted data
and assessed the quality of included studies using the Newcastle-Ottawa assessment scale.
We searched Medline, Embase, PsychInfo, CINAHL, Web of Science, LILACS or AMED,
between January 1946 and September 2012, and recent conference abstracts. We included
registries, databases or cohort studies which described the number of fatal food anaphy-
laxis cases in a defined population and time period and applied an assumed population
prevalence rate of food allergy.
Results We included data from 13 studies describing 240 fatal food anaphylaxis episodes
over an estimated 165 million food-allergic person-years. Study quality was mixed, and
there was high heterogeneity between study results, possibly due to variation in food
allergy prevalence and data collection methods. In food-allergic people, fatal food ana-
phylaxis has an incidence rate of 1.81 per million person-years (95%CI 0.94, 3.45; range
0.63, 6.68). In sensitivity analysis with different estimated food allergy prevalence, the
incidence varied from 1.35 to 2.71 per million person-years. At age 0–19, the incidence
rate is 3.25 (1.73, 6.10; range 0.94, 15.75; sensitivity analysis 1.18–6.13). The incidence of
fatal food anaphylaxis in food-allergic people is lower than accidental death in the gen-
eral European population.
Conclusion Fatal food anaphylaxis for a food-allergic person is rarer than accidental
death in the general population.
Keywords anaphylaxis, food allergy, mortality, systematic review
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Introduction
Food allergy affects up to 10% of young children and
2–3% of adults, and appears to be increasing in preva-
lence [1, 2]. Food allergy is the commonest cause of
anaphylaxis, which can be fatal, but the precise inci-
dence of fatal anaphylaxis for food-allergic people is
unknown. Uncertainty about the absolute level of risk
associated with food allergy may be an important con-
tributor to wider uncertainties over service provision
for food allergy, food labelling legislation and manage-
ment strategies. We undertook a systematic review to
quantify the incidence of fatal anaphylaxis for food-
allergic people. We estimated the incidence rate of fatal
food anaphylaxis in a food-allergic individual, and
compared this with the incidence of other risks for peo-
ple living in the United States or Europe. In view of
previous findings that peanut allergy and young age
may be risk factors for fatal food anaphylaxis, we
undertook subgroup analyses for young people (aged
0–19) with food allergy and for peanut-allergic peo-
ple [3]. In view of the uncertainty about food allergy
prevalence in different populations, we undertook sensi-
tivity analysis to explore the effect of varying food
allergy prevalence estimates, on fatal food anaphylaxis
incidence.
Methods
Data sources
This review was undertaken and reported in accordance
with MOOSE guidance [4]. We searched Medline,
Embase, PsycINFO, Web of Science, Allied and
Complementary Medicine (AMED), Latin American and
Caribbean Health Science Information database
(LILACS) and Cumulative Index to Nursing and Allied
Health Literature (CINAHL) for articles published
between January 1946 and 5 September 2012 which
described food anaphylaxis incidence – the Medline
search strategy is shown in the Supporting Information
Data S1, and similar searches were used for other data-
bases. We searched abstracts from the 2011 and 2012
meetings of the American Academy of Asthma Allergy
and Immunology (AAAAI) and the European Academy
of Allergy and Clinical Immunology (EAACI) using
‘food allergy’ and ‘anaphylaxis’. We searched US
national data (CDC Wonder, Centers for Disease Control
and Prevention) and European Union-27 data (Eurostat,
European Commission) for incidences of other fatal and
non-fatal events. There was no registered protocol for
this review, but the methods and analyses were planned
a priori. No language restrictions were made, and we
planned to include non-English papers if they met our
inclusion criteria.
Study selection
Two authors (TU, RJB) independently screened titles
and abstracts, and selected studies. Disagreements were
resolved by discussion. We reviewed reference lists of
included studies and review articles to identify other
studies. Inclusion criteria were as follows: (i) Study
design: Registries, databases or cohort studies including
≥1 case of fatal food anaphylaxis. (ii) Participants: A
defined population where an assumed population rate
of food allergy could be applied. (iii) Follow-up: To
enable calculation of total person-years of observation,
we included studies that specified either total popula-
tion and duration of data collection, or anaphylaxis
incidence rate. (iv) Outcomes: We included reports of
number of fatal food anaphylaxis events during the
follow-up period. Exclusion criteria were as follows: (i)
fatalities neither probably nor definitely due to anaphy-
laxis, in the judgement of the original study authors;
(ii) time period not defined; (iii) population in which
food anaphylaxis cases occurred could not be quanti-
fied. Studies needed to satisfy all 4 inclusion criteria
and none of the exclusion criteria, to be included in the
review. Where population number was not described in
the study, we derived total populations and populations
aged 0–19 using regional public health databases. We
contacted the author of one study to ask for their origi-
nal data set [5]. Where more than one study covered
the same population during an overlapping time period,
we included the study covering the greatest number of
person-years.
Data extraction
Two authors (TU, RJB) independently extracted data,
and quality assessed the included studies. Differences
were resolved by discussion. When available, we sepa-
rately extracted data for younger people (age 0–19),
and those with peanut allergy. We estimated incidences
for the total food-allergic population, and subgroups of
aged 0–19 years and peanut allergy. Where studies
were restricted to a population aged < 19, data were
only used for the 0–19 subgroup, and likewise for
peanut allergy. For quality assessment, we used the
Newcastle-Ottawa quality assessment scale for cohort
studies with one modification [6]. Under the criterion
‘was follow-up long enough for outcomes to occur’, we
considered studies with at least 20 fatal food anaphy-
laxis cases to satisfy this criterion. Studies were consid-
ered poor quality for Newcastle-Ottawa score < 2.
Data synthesis
For each study, number of events and total person-years
of monitoring were extracted, and incidence rate calcu-
lated per million person-years [micromort]. Rates were
pooled across studies using the natural logarithm of the
occurrence rate and its standard error (estimated using
1/√events) based on a random effect model using the
generic inverse variance method (STATA version 12 IC;
Stata Corporation, College Station, TX, USA). Heteroge-
neity was assessed using I2. For meta-analyses including
≥10 studies, we assessed publication bias using Funnel
plots. We conducted meta-analysis even if significant
heterogeneity was seen between study estimates, but
explored possible reasons in sensitivity analyses, includ-
ing study quality. For calculations, we estimated the
population food allergy prevalence as 3% overall, 3.9%
for a 0–19 year old, 1% for peanut allergy, but explored
the effect of different prevalence estimates in sensitivity
analyses due to the considerable uncertainty in the liter-
ature surrounding food allergy prevalence in different
populations [2, 7, 8]. We assumed that all fatal food ana-
phylaxis would occur in this population. We made no
separate analysis of incidence according to sex, due to
insufficient gender-specific data from included studies.
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Estimation of comparator risks
We selected sudden unexpected occurrences with recent
reliable population-based information as comparator
risks using US and EU-27 data. Emergency department
attendances for a motor vehicle accident (E810-E819,
E958.5, E968.5, E988.5), total emergency department
attendance rates and attendances due to an injury
(E800-E848, E850-E869, E880-E929) were extracted
from National Center for Health Statistics data for 2006–
2008 (CDC Wonder, Centers for Disease Control and Pre-
vention). Fatality data including murder (X85-Y09), fire
(X00-X09), all accidents (V01-99 or W00-X59), light-
ning (X33) and all cause mortality were extracted from
the same data source for 2005–2007. European data
using the same codes and time periods were extracted
from Eurostat for the EU-27 population (Eurostat, Euro-
pean Union). The data used were not age adjusted.
Results
Our search identified 2552 original titles. Title screen-
ing yielded 459 abstracts, and 156 full articles were
reviewed for potential relevance. We identified 13
studies describing a total of 240 deaths from food
anaphylaxis over an estimated 165 million food-
allergic person-years [3, 5, 9–19]. We were unable to
include a further 14 population-based studies of
anaphylaxis incidence rates (covering an estimated
4 million food-allergic person-years) in our analyses,
due to no fatalities recorded (listed in Supporting
Information Data S1). Search results are shown in
Fig. 1, and characteristics of included studies in
Table 1. All included studies contributed to at least
one meta-analysis.
Incidence rate of fatal food anaphylaxis in food-allergic
people
Assuming a food allergy prevalence rate of 3% (3.9%
in those aged 0–19 and 1% for peanut allergy), meta-
analysis estimates the incidence rate of fatal food ana-
phylaxis in a food-allergic person as 1.81 (95% CI
0.94, 3.45; range 0.63, 6.68) per million person-years
(micromorts) based on 10 studies [3, 5, 9, 10, 12–14, 16,
18, 19], 3.25 (1.73, 6.10; range 0.94, 15.75) micromorts
Total titles: 2970
459 abstracts screened
156 articles screened
Relevant articles identified 13
Abstract screen excluded 303
No relevant data 134
Case report 25
Review article 68
No denominator population 76
Article screen excluded 143
No relevant data 108
Review article 6
No denominator population18
Used another related article 11
Title screen excluded 2093
No relevant data 1361
Case report 138
Review article 547
Opinion 47
Medline and Embase  
1562
Web of Science 
763
Included in the review 13
CINAHL
193
PsychInfo
166
LILACS
133
Duplicates 418
Original references: 2552
AMED
150
Conference 
abstracts 3
Fig. 1. PRISMA flow chart showing results of literature search.
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in those aged 0–19 based on 10 studies [3, 5, 10–13,
15–18] and 2.13 (1.09, 4.16; range 1.03, 8.77) micro-
morts for peanut allergy based on seven studies [3, 5,
10, 12–14, 16] (Fig. 2a–c). All meta-analyses showed
high levels of heterogeneity. Rates were higher in the
smallest series, and this is reflected in the Funnel plot
for all ages (Fig. 3a), but overall there was no clear evi-
dence of publication bias in either all ages or those
aged 0–19 (Fig. 3b) [9–11]. Rates were also higher in
the Canadian study of Salter, for unknown reasons
[16]. Our sensitivity analysis excluding poor-quality
studies [10, 17, 18] found decreased fatal food anaphy-
laxis rate overall – 1.57 (0.75, 3.27; range 0.63, 6.68),
in 0–19 year olds – 2.70 (1.31, 5.54; range 0.94, 9.74)
and in peanut allergy – 2.04 (1.01, 4.13; range 1.03,
8.77) but heterogeneity of study outcomes remained
significant. In 4 of the included studies, data were
available for non-fatal food anaphylaxis rates in the
same population and time period [9–11, 13]. Case fatal-
ity rates ranged from 33% of patients admitted to an
intensive care unit [10] to 0.14% of patients admitted
to hospital [13].
Comparison of food allergy risks with other age-specific
risks
Figure 4 shows the estimated incidence of fatal food
anaphylaxis for a food-allergic person (Fig. 4a) and a
food allergic 0–19 year old (Fig. 4b), in comparison
with incidences of other events for the general popula-
Table 1. Characteristics of included studies
Study Setting Case identification/numbers Source of denominator population
Quality
score*
Bock [9] Colorado USA
1990–1991
Emergency department survey – identified cases of
probable fatal food anaphylaxis. 1 fatality
Colorado population statistics 2/4
Foucard & Malmheden
Yman [10]
Sweden
1993–1996
Survey of physicians, with case notes scrutinized by a
single investigator. 4 fatalities
Sweden population statistics 1/4
Calvani et al. [11] Lazio, Italy
2000–2003
Hospital and emergency department information
system: ICD codes 708.0, 989.5, 995.0, 995.2, 995.3,
995.4, 995.6, 999.4. 1 fatality
Lazio population aged 0–17 cited
in paper
2/4
Pumphrey &
Gowland [5]†
United Kingdom
1992–2009
Prospective registry using national statistics, network of
coroners, allergy charity to identify cases. Death
certificate coding for anaphylaxis. 104 fatalities
UK population statistics 3/4
Bock et al. [12] USA
2001–2006
Prospective registry. Cases reported by physicians,
media and FAAN and confirmed by a structured
questionnaire. 31 fatalities
US population statistics
2001–August 2006
2/4
Liew et al. [13] Australia
1997–2005
National Mortality Database – Death certificate ICD-10
codes T78.0, T78.2, T80.5, T88.6, T78.1, T78.4, X23,
X25. Review of cases via Coroner reports and media
archives. 7 fatalities
Mid-2001 Australian population
figures used, multiplied by 9
2/4
Simon & Mulla [14] Florida, USA
1996–2005
Death certificate search ICD-9 codes 995.0, 999.4 for
1996–1998; ICD-10 codes T50.9, T63.2, T63.4, T63.6,
T63.9, T78.0, T78.2, T80.5, T88.6 for 1999–2005.
All death certificates reviewed by a single author.
7 fatalities
Florida population estimates cited
in paper
2/4
Bock [3] USA
1994–1999
Prospective registry. Cases reported by relatives, in
response to advertising. 32 fatalities
US population statistics 2/4
Lin et al. [15] New York State
USA
1990–2006
Statewide hospitalization database: ICD-9 code 995.6. 4
fatalities
New York State population aged
0–19, calculated from
anaphylaxis rates cited in paper
2/4
Salter et al. [16] Ontario, Canada
1986–2000
Death certificate search for anaphylaxis as cause of
death. 32 fatalities
Ontario population statistics 3/4
Simons et al. [17] Canada
2000–2001
Survey of paediatricians [Canadian Paediatric
Surveillance Programme]. 1 fatality
Canada population aged 0–17 in
2000
0/4
Levy et al. [18] Israel
2004–2011
Discussion with regional allergists, search of national
media. 4 fatalities
Israel population estimates cited in
paper
0/4
Tanno et al. [19] Brazil
2008–2010
Death certificate search using extensive ICD-10 codes,
and review of all records where anaphylaxis was a
possible cause of death. 12 fatalities
Brazilian population calculated
from anaphylaxis rates cited in
paper
2/4
*Quality assessment based on Newcastle-Ottawa scale for Cohort Studies [6].
†Extended dataset kindly provided by study author.
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NOTE: Weights are from random effects analysis
Overall (I−squared = 94.8%, P = 0.000)
Salter 2003
Tanno 2012
Simon 2008
Liew 2009
Bock 2007
Foucard 1999
ID
Study
Levy 2012
Bock 2001
Pumphrey 2009
Bock 1992
1.81 (0.94, 3.45)
6.68 (4.73, 9.45)
0.70 (0.40, 1.23)
1.39 (0.66, 2.92)
1.37 (0.65, 2.87)
0.63 (0.44, 0.89)
5.03 (1.89, 13.41)
rate (95% CI)
Fatality
2.30 (0.86, 6.12)
0.66 (0.46, 0.93)
3.26 (2.69, 3.95)
4.98 (0.70, 35.35)
100.00
11.24
10.67
10.08
10.08
11.23
9.17
Weight
%
9.17
11.24
11.49
5.63
.25 .5 1 2 5 10
Micromorts
NOTE: Weights are from random effects analysis
Overall (I−squared = 88.1%, P = 0.000)
Study
Pumphrey 2009
Bock 2001
Lin 2008
Salter 2003
Foucard 1999
Simons 2004
ID
Levy 2012
Liew 2009
Calvani 2008
Bock 2007
3.25 (1.73, 6.10)
Fatality
4.53 (3.40, 6.03)
1.10 (0.71, 1.70)
2.44 (0.92, 6.51)
8.22 (4.55, 14.84)
15.75 (5.91, 41.97)
1.97 (0.28, 13.97)
rate (95% CI)
3.66 (1.18, 11.34)
2.18 (0.83, 5.73)
9.74 (1.37, 69.17)
0.94 (0.59, 1.52)
100.00
%
12.81
12.37
9.98
11.79
9.98
5.78
Weight
9.23
10.03
5.78
12.24
.1 1 5 10 50
Micromorts
NOTE: Weights are from random effects analysis
Overall (I−squared = 86.4%, P = 0.000)
Bock 2007
ID
Study
Pumphrey 2009
Foucard 1999
Bock 2001
Liew 2009
Simon 2008
Salter 2003
2.13 (1.09, 4.16)
1.03 (0.64, 1.66)
rate (95% CI)
Fatality
1.57 (0.98, 2.53)
3.68 (0.52, 26.13)
1.23 (0.79, 1.91)
1.76 (0.57, 5.45)
2.39 (0.90, 6.37)
8.77 (5.19, 14.81)
100.00
16.89
Weight
%
16.89
7.16
17.11
12.10
13.24
16.59
.5 1 2 5 10 50
Micromorts
(a)
(b)
(c)
Fig. 2. Estimated rate of fatal food anaphylaxis for a food-allergic person (a), a food-allergic person aged 0–19 (b) and a peanut-allergic person
(c) expressed as incidence rate per million person-years (micromort).
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tion in US or Europe. Incidence of fatal food anaphy-
laxis for a food-allergic person is ≥100 times lower
than incidence of death due to any accident in the
general population, and at age 0–19, the incidence is
≥10 times lower than accidental death incidence in the
general population.
Sensitivity of fatal food anaphylaxis incidence rate to
changes in food allergy prevalence
Table 2 shows how fatal food anaphylaxis incidence
rate varies with different estimated food allergy preva-
lence rates. For the highest estimates of population food
allergy prevalence, the pooled incidence rate of fatal
food anaphylaxis for a food-allergic person falls to 1.35
(0.71, 2.59), 1.18 (0.63, 2.22) at aged 0–19 and 0.73
(0.38, 1.43) for peanut allergy. For the lowest estimates
of population food allergy prevalence, the pooled inci-
dence rate of fatal food anaphylaxis rises to 2.71 (1.42,
5.17), 6.13 (3.25, 11.56) at aged 0–19 and 4.25 (2.17,
8.31) for peanut allergy.
Discussion
In this systematic review, we evaluated the incidence
rate of fatal food anaphylaxis in people with food
allergy, and compared this with general population
incidence rates for other unexpected medical events. In
all studies and all subgroups evaluated, the incidence
rate of fatal food anaphylaxis in food-allergic people is
lower than the rate of accidental death in the general
population. While it is possible that specific groups of
food-allergic people have a higher incidence of fatal
food anaphylaxis, such groups cannot yet be easily
identified in clinical practice.
Fatal food anaphylaxis is a rare, dramatic event
which often involves young people and commands
wide media attention – as with other high profile, rare
events the public perception of risk may be signifi-
cantly greater than the true risk [20]. Given the impor-
tance of anxiety as a contributor to the quality of life
impact of food allergy [21], our finding that fatal food
anaphylaxis incidence is relatively low may be impor-
tant information for food-allergic people and their
carers. Some people with food allergy and their fami-
lies have restricted lives because of fear of anaphylaxis
and fatal outcomes, which they may estimate to be
more likely to occur than reality. The extent to which
such lifestyle restrictions are effective for preventing
fatal outcomes is unclear. Our findings allow for a
more accurate appraisal of fatal food anaphylaxis inci-
dence and will inform debate over clinical practice,
healthcare provision, school and community policies
and food labelling regulation in relation to food
allergy.
The limitations of this systematic review mainly
relate to variations between studies in method of data
capture and case definition of fatal food anaphylaxis,
and limited information about food allergy prevalence
in the populations studied. We are also unable to
exclude the possibility of a systematic bias operating
across different studies, in either the acquisition and
coding of fatal food anaphylaxis data or the estimation
of food allergy prevalence. Given the potential diffi-
culty of identifying all those with fatal food anaphy-
laxis, there was reasonable consistency between studies
in the estimated incidence rate in US, UK, Italy, Austra-
lia, Sweden, Brazil, Israel and Canada over 3 decades.
The heterogeneity between study results may be partly
explained by varying method of data capture – studies
relied on a mixture of reporting through patient chari-
ties, professional bodies and networks, media reports
and coroner reports. Variations in medical management
of anaphylaxis may have also contributed to varying
fatality rates. However, all studies found the incidence
rate to be low – less than once every 100 000 person-
years in the highest quality studies. We estimated food
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Fig. 3. Funnel plots to assess risk of publication bias in analysis of
overall fatal food anaphylaxis incidence rate (a) and fatal food ana-
phylaxis incidence rate at age 0–19 (b).
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allergy as 3% overall, 3.9% at age 0–19 and 1% for
peanut allergy. In reality, estimates of food allergy
prevalence vary considerably between studies. Our
sensitivity analysis showed fatal food anaphylaxis inci-
dence rate varies with varying food allergy prevalence
estimates, but under all assumptions, the rate remains
less than once every 100 000 person-years. Recently,
Australian and US data found a higher prevalence of
food allergy and peanut allergy in children than previ-
ously reported, and many studies of food allergy preva-
lence have failed to systematically identify allergy to
all possible food allergens, suggesting that fatal food
Definite 1 in 10 1 in 100 1 in 1 000 1 in 10 000 1 in 100 000 1 in 1 million 1 in 10 million 1 in 1 billion1 in 100 million
Annual incidence rate for different events in food allergic people
Fatal food anaphylaxis
Annual incidence rate for different events in food allergic people aged 0-19
Definite 1 in 10 1 in 100 1 in 1 000 1 in 10 000 1 in 100 000 1 in 1 million 1 in 10 million 1 in 1 billion1 in 100 million
Fatal food anaphylaxis
(a)
(b)
Fig. 4. Estimated risk of fatal food anaphylaxis for a food-allergic person (a) or food-allergic person aged 0–19 (b), compared with other popula-
tion risks. Continuous bar represents mean with 95% confidence interval; dotted bar is the range of point estimates from individual studies. Where
reference risks vary markedly between European and United States populations, they are stated separately. Otherwise, reference risks are for a Uni-
ted States population.
Table 2. Fatal food anaphylaxis incidence rates – calculated using different estimated food allergy prevalence rates
Estimated food allergy prevalence*
Mean (95% CI) mortality
rate (micromorts)
All fatal food anaphylaxis Food allergy prevalence 4% [2] 1.35 (0.71, 2.59)
Food allergy prevalence 3% [2] 1.81 (0.94, 3.45)
Food allergy prevalence 2% [2] 2.71 (1.42, 5.17)
Fatal food anaphylaxis in
young people (age 0–19)
Food allergy prevalence 10.4% [1] 1.18 (0.63, 2.22)
Food allergy prevalence 3.9% [7] 3.25 (1.73, 6.10)
Food allergy prevalence 2% [2] 6.13 (3.25, 11.56)
Fatal peanut anaphylaxis Peanut allergy prevalence 2.9% [1] 0.73 (0.38, 1.43)
Peanut allergy prevalence 1% [2] 2.13 (1.09, 4.16)
Peanut allergy prevalence 0.5% [2] 4.25 (2.17, 8.31)
*Estimated prevalence rates are taken from the meta-analysis of Rona et al. [2], for symptoms of food allergy and a positive allergy test, or for
some estimates from more recent studies [1, 7].
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anaphylaxis incidence may be towards the lower end of
our range of estimates [1, 22].
Life-threatening asthma is associated with food
allergy, and fatal food anaphylaxis may present with
acute wheezing [23]. A subgroup of fatal asthma cases
occurs rapidly with less marked eosinophilic airway
inflammation [24, 25] – if some of these cases are fatal
food anaphylaxis, then we may have underestimated
fatal food anaphylaxis incidence due to miscoding as
fatal asthma. A Swedish study found 11 of 37 (30%)
fatal asthma cases at ages 1–34 were triggered by
ingestion of a food allergen, raising this possibility
[26]. However, the study included ICD codes for ana-
phylaxis (995 and T78.0) in the original search, and it
is unclear how many of the 11 fatal food anaphylaxis
cases had actually been classified as fatal asthma. Other
studies have failed to identify miscoding of fatal food
anaphylaxis as fatal asthma. A Finnish study evaluat-
ing the validity of death certificate coding of asthma
deaths [27] from 1976 to 1998 did not reveal any mis-
coded fatal food anaphylaxis cases, nor did a similar
analysis of UK asthma deaths in young people over
1 year [5].
We were unable to identify a group of food-allergic
people with markedly different outcomes, however
previous work has identified that those with asthma,
previous severe reaction, IgE binding to a diverse range
of epitopes, deficient platelet-activating factor acetyl-
hydrolase or serum angiotensin-converting enzyme
may have more severe food-allergic reactions [28–30].
One might expect patient education, the frequency with
which a food is used as an ingredient, and allergen
avoidance behaviour to influence an individual’s risk,
and there is some evidence to support this for non-fatal
food anaphylaxis [31]. Those with food allergy second-
ary to inhalant sensitization, without asthma, and with
previous mild reactions may be at lower incidence.
Asthma is commonly cited as a risk factor for fatal food
anaphylaxis, but while 85–96% of fatal food anaphy-
laxis occurs in people with asthma [3, 5], asthma is
present in 29–76% of all food-allergic people [7, 32].
Hence, the predictive value of an asthma diagnosis for
risk of fatal food anaphylaxis is poor. More work is
needed to identify tools for risk stratification and
reduction in food-allergic people [33].
In conclusion, we have quantified the incidence rate
of fatal food anaphylaxis for food-allergic people.
Although fatal food anaphylaxis is a rapid and fright-
ening event, it appears to be very rare, such that for
most food-allergic people, the incidence of fatal food
anaphylaxis is likely to add relatively little to their
overall mortality risk. This information should not
belittle the concerns of food-allergic people and their
families, and appropriate education, food labelling,
allergen avoidance and anaphylaxis management strat-
egies remain important. Our findings do, however, put
the level of risk in perspective and may provide some
reassurance to those affected by food allergy.
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